Clinical trials sponsored by Institut du Cancer de Montpellier - Val d'Aurelle

Phase breakdown

Conditions studied

Recruiting trials led by Institut du Cancer de Montpellier - Val d'Aurelle

• A Clinico-biological Database in Cachexia in Patients With Colon Cancer
  NCT05257135 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Clinicobiological Database in Metastatic Digestive Cancers
  NCT03978078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Analysis of Circulating Tumor Markers in Blood
  NCT04025541 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Clinical and Biological Database in Colon Cancer and Colic Tumors
  NCT03976960 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
  NCT04104529 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers
  NCT04103567 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Development of Clinical and Biological Database
  NCT03449264 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Development of a Clinical and Biological Database in Rectum Cancer
  NCT04006951 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
  NCT05065801 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 8 locations
• Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
  NCT04024917 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer
  NCT04823923 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life
  NCT04356209 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability
  NCT06382818 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
  NCT06144762 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery
  NCT06265558 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 7 locations
• Prospective Monocentric Clinical-biological Database
  NCT04136132 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology
  NCT06053086 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
  NCT04570943 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 9 locations
• Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
  NCT04749108 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• Study of Sexual Quality of Life in Women With Breast Cancer Who Had Multidisciplinary Management With Photobiomodulation for Genitourinary Syndrome of the Menopause
  NCT06347926 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials is Institut du Cancer de Montpellier - Val d'Aurelle recruiting for?

Institut du Cancer de Montpellier - Val d'Aurelle is the lead sponsor of 20 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.